Oral Antiplatelet Agents in Dialysis Patients: Friends or Foes?

Autor:	Costas Fourtounas, Aggeliki Panagiotou
Rok vydání:	2013
Předmět:	Aspirin medicine.medical_specialty Heel business.industry medicine.medical_treatment medicine.disease Clopidogrel Thrombosis Uremia medicine.anatomical_structure Internal medicine medicine Polycystic kidney disease Cardiology business Intensive care medicine Dialysis medicine.drug Kidney disease
Zdroj:	General Medicine: Open Access.
ISSN:	2327-5146
DOI:	10.4172/2327-5146.1000109
Popis:	Thrombotic cardiovascular events are one of the main causes of morbidity and mortality in dialysis patients [1] and vascular access thrombosis remains the Achilles’ heel for patients undergoing maintenance hemodialysis (HD) [2]. HD and uremia are characterized by two simultaneous but opposite hematological abnormalities: a thrombotic predisposition and a bleeding tendency mainly due to impaired platelet-platelet and platelet-vessel wall interactions [3-5].
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cc8f4c843541d3683af8e4b75f15f77d https://doi.org/10.4172/2327-5146.1000109 Zobrazit plný text záznamu